Loading clinical trials...
Loading clinical trials...
A Long-term Follow-up Study to Evaluate the Injection of EXG102-031 Ophthalmic Injection in Participants With Wet Age-related Macular Degeneration (wAMD).
Conditions
Interventions
No intervention, only for observational studies
Locations
1
China
Peking University People's Hospital
Beijing, China
Start Date
March 13, 2025
Primary Completion Date
May 15, 2030
Completion Date
December 1, 2030
Last Updated
August 15, 2025
NCT05407636
NCT06718816
NCT04932980
NCT07389577
NCT05381948
NCT07178249
Lead Sponsor
Guangzhou Jiayin Biotech Ltd
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions